Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like Imprimis Announces First Quarter 2017 Financial Results May 10, 2017 Frost & Sullivan Release: Evolving Pharmaceutical Ecosystem Transforms Clinical Trials And Research Outsourcing June 15, 2017 Eli Lilly Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs July 24, 2017
Frost & Sullivan Release: Evolving Pharmaceutical Ecosystem Transforms Clinical Trials And Research Outsourcing June 15, 2017